Yu Hou

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Ejection Fraction

Acute Lymphoblastic Leukemia

Recombinant Human

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology (2024)
Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology 99 (7) (2024)
Lingjun Wang, Haoyi Wang, Mingfang Zhu, Xiaofei Ni, Lu Sun, Wanru Wang, Jie Xie, Yubin Li, Yitong Xu, Ruting Wang, Shouqing Han, Ping Zhang, Jun Peng, Ming Hou, Yu Hou
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia. Blood 144 (1) (2024)
Yan Shi, Hu Zhou, Ruibin Huang, Fang Wang, Heng Mei, Lie Lin, Jingming Guo, Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou, Yu Hou, Ming Hou
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia. American journal of hematology 99 (7) (2024)
Lingjun Wang, Haoyi Wang, Mingfang Zhu, Xiaofei Ni, Lu Sun, Wanru Wang, Jie Xie, Yubin Li, Yitong Xu, Ruting Wang, Shouqing Han, Ping Zhang, Jun Peng, Ming Hou, Yu Hou
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia. Blood 144 (1) (2024)
Lu Sun, Xiaoyang Huang, Juan Wang, Chenglu Yuan, Hongyu Zhao, Daqi Li, Rui-Rong Xu, Yan Wang, Pin Qin, Yan Shi, Jun Peng, Ming Hou, Yu Hou
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial. Blood (2024)
Lingjun Wang, Haoyi Wang, Mingfang Zhu, Xiaofei Ni, Lu Sun, Wanru Wang, Jie Xie, Yubin Li, Yitong Xu, Ruting Wang, Shouqing Han, Ping Zhang, Jun Peng, Ming Hou, Yu Hou
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia. Blood (2024)
Yu Hou, Jie Xie, Shuwen Wang, Daqi Li, Lingjun Wang, Haoyi Wang, Xiaofei Ni, Shaoqiu Leng, Guosheng Li, Ming Hou, Jun Peng
Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cellular & molecular immunology 19 (7) (2022)
Qidi Chen, Min Xin, Lingjun Wang, Lin Li, Yingzhi Shen, Yan Geng, Haojie Jiang, Yang Wang, Lin Zhang, Yanyan Xu, Yu Hou, Junling Liu, Xuemei Fan
Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis. Blood 139 (19) (2022)
Xiaofei Ni, Daqi Li, Chenglu Yuan, Yafei Yu, Haoyi Wang, Lingjun Wang, Tianshu Yu, Ping Qin, Jun Peng, Ming Hou, Yan Shi, Yu Hou
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study. American journal of hematology 97 (4) (2022)
Yanming Wang, Tianshu Yu, Qiaofeng Dong, Shuang Liu, Yafei Yu, Hong Yu Zhao, Ji Ma, Lin Dong, Liang Wang, Daoxin Ma, Yajing Zhao, Yu Hou, Xin-Guang Liu, Jun Peng, Ming Hou
Clonal hematopoiesis in primary immune thrombocytopenia. Blood cancer journal 12 (3) (2022)
Haiyu Zhang, May Chien, Yu Hou, William Shomali, Rondeep Brar, Chandler Ho, Panpan Han, Danfei Xu, Bing M Zhang, Xiangqian Guo, Lorna Tolentino, Nancy C Wu, Albert G Tsai, Jing Jin, Wesley Holbrook Witteles, Zhenping Chen, Parveen Abidi, Diwash Jangam, Madison S Krieger, Morgan Craig, James B Bussel, Jason R Gotlib, James L Zehnder
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3, and MPL mutations. Blood advances (2022)
Panpan Han, Yu Hou, Yajing Zhao, Yang Liu, Tianshu Yu, Yunqi Sun, Haoyi Wang, Pengcheng Xu, Guosheng Li, Tao Sun, Xiang Hu, Xinguang Liu, Lizhen Li, Jun Peng, Hai Zhou, Ming Hou
Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia. Blood 138 (8) (2021)
Yunqi Sun, Yu Hou, Guiyue Meng, Panpan Han, Yajing Zhao, Haoyi Wang, Miao Xu, Yawen Wang, Jihua Qiu, Jun Peng, Linlin Shao, Lu Sun, Ming Hou
Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia. British journal of haematology 194 (6) (2021)
Ya-Fei Yu, Yu Hou, Yajing Zhao, Hai Zhou, Fangmiao Jing, Yanfeng Liu, Jun Peng, Xin-Guang Liu, Ming Hou
Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia. British journal of haematology 194 (1) (2021)
Tian-Shu Yu, Hao-Yi Wang, Ya-Jing Zhao, Ya-Fei Yu, Yu Hou, Shuang Liu, Pan-Pan Han, Xiao-Fei Ni, Xue-Bin Ji, Jun Peng, Xin-Guang Liu, Ming Hou
Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood advances 5 (20) (2021)
Pengcheng Xu, Yajing Zhao, Tianshu Yu, Yafei Yu, Xiaofei Ni, Haoyi Wang, Lu Sun, Panpan Han, Lingjun Wang, Tao Sun, Xin-Guang Liu, Hai Zhou, Jun Peng, Ming Hou, Yu Hou, Miao Xu
Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro. British journal of haematology (2021)
Lingjun Wang, Lizhen Li, Chaoyang Li, Yu Hou, Miao Xu, Ya-Fei Yu, Xiaofei Ni, Ruting Wang, Haoyi Wang, Lin Wang, Jun Peng, Ming Hou
Significance of anti-HBc serological status in primary immune thrombocytopenia. British journal of haematology (2021)
Yafei Yu, Miaomiao Wang, Yu Hou, Ping Qin, Qingshu Zeng, Wenzheng Yu, Xinhong Guo, Jingxia Wang, Xiaomin Wang, Guoqiang Liu, Xiaoxia Chu, Lan Yang, Ying Feng, Fang Zhou, Zhaogang Sun, Mei Zhang, Xin Wang, Zhencheng Wang, Xuehong Ran, Hongguo Zhao, Lei Wang, Haiyan Zhang, Kehong Bi, Daqi Li, Chenglu Yuan, Ruirong Xu, Yili Wang, Yuhong Zhou, Jun Peng, Xin-Guang Liu, Ming Hou
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial. American journal of hematology 95 (12) (2020)